Baglivo, S.; Ricciuti, B.; Ludovini, V.; Metro, G.; Siggillino, A.; De Giglio, A.; Chiari, R., Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation, «JOURNAL OF THORACIC ONCOLOGY», 2018, 13, pp. 145 - 147 [articolo]
De Giglio, A.; Porreca, R.; Brambilla, M.; Metro, G.; Prosperi, E.; Bellezza, G.; Pirro, M.; Chiari, R.; Ricciuti, B., Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?, «THROMBOSIS RESEARCH», 2018, 163, pp. 51 - 53 [articolo]
Ricciuti, B.; De Giglio, A.; Mecca, C.; Arcuri, C.; Marini, S.; Metro, G.; Baglivo, S.; Sidoni, A.; Bellezza, G.; Crino, L.; Chiari, R., Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib, «MEDICAL ONCOLOGY», 2018, 35, Article number: 72, pp. 1 - 18 [articolo]
Ricciuti, B.; Baglivo, S.; Paglialunga, L.; De Giglio, A.; Bellezza, G.; Chiari, R.; Crino, L.; Metro, G., Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Rationale, evidence and place in therapy, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2017, 9, pp. 387 - 403 [articolo]Open Access
Ricciuti, B.; Leonardi, G. C.; Ravaioli, N.; De Giglio, A.; Brambilla, M.; Prosperi, E.; Ribacchi, F.; Meacci, M.; Crino, L.; Maiettini, D.; Chiari, R.; Metro, G., Ductal breast carcinoma metastatic to the stomach resembling primary linitis plastica in a male patient, «JOURNAL OF BREAST CANCER», 2016, 19, pp. 324 - 329 [articolo]
